A carregar...
IMMU-22. PHARMACOLOGICALLY TARGETING EXTRACELLULAR VESICLE-IMMUNE CELL INTERACTIONS IN GLIOBLASTOMA
Glioblastoma (GBM) is the most aggressive type of primary brain cancer and carries a dire prognosis. Increasing evidence points to extracellular vesicles (EVs) as a means by which GBM tumor cells modulate the tumor microenvironment, leading to immunosuppression and disease progression. Several pharm...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217289/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.525 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|